Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121592) titled 'Individualized Dynamic Risk Prediction, Clinical Decision-Making Utility... Read More
Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121596) titled 'The effects of different vinegar-containing beverages on the blood sugar... Read More
Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121599) titled 'Surveillance and Prevention Strategies for Influenza Viruses in Fever Cl... Read More
Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121603) titled 'Study on the Impact of Short-term ONS on Body Composition and Quality of... Read More
Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121607) titled 'Clinical Application Study of Novel 18F-Labeled N-Heteroaromatic a-Synuc... Read More
Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121611) titled 'Firmonertinib for Adjuvant Therapy in Completely Resected Stage IA EGFR-... Read More
Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121615) titled 'A Study on the Correlation Between Systemic Immune Inflammation Index an... Read More
Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121619) titled 'Comparison of the consistency of retinal periphery refractive status mea... Read More
Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121622) titled 'The predictive value of rectus femoris cross-sectional area for hypotens... Read More
Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121627) titled 'Real-World Study of First-Line Treatment with Trastuzumab Biosimilar and... Read More